Total Payments
$5,242
2024 Payments
$560.11
Companies
30
Transactions
279
Medicare Patients
27,349
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$5,235 (99.9%)
Education$7.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,235 | 278 | 99.9% |
| Education | $7.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $895.19 | 57 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $524.88 | 33 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $471.94 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $447.76 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $376.64 | 19 | $0 (2024) |
| Amgen Inc. | $370.26 | 21 | $0 (2024) |
| PFIZER INC. | $286.80 | 18 | $0 (2024) |
| Gilead Sciences, Inc. | $233.01 | 33 | $0 (2019) |
| Medtronic, Inc. | $232.02 | 2 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $231.35 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $560.11 | 27 | Merck Sharp & Dohme LLC ($101.89) |
| 2023 | $959.12 | 32 | Abbott Laboratories ($127.77) |
| 2022 | $322.87 | 18 | Merck Sharp & Dohme LLC ($121.01) |
| 2021 | $466.93 | 15 | Cardiovascular Systems Inc. ($147.77) |
| 2020 | $215.60 | 12 | Amgen Inc. ($68.85) |
| 2019 | $891.56 | 50 | Boehringer Ingelheim Pharmaceuticals, Inc. ($150.94) |
| 2018 | $1,294 | 94 | Novartis Pharmaceuticals Corporation ($262.26) |
| 2017 | $532.22 | 31 | Novartis Pharmaceuticals Corporation ($192.76) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.24 | General |
| Category: Cardiovascular | ||||||
| 09/10/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/06/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Cardiology | ||||||
| 07/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.69 | General |
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.35 | General |
| Category: Cardiovascular | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Cardiology | ||||||
| 05/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Cardiology | ||||||
| 05/09/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/08/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/23/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $30.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/12/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/07/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: DIABETES | ||||||
| 02/27/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 6,496 | 9,760 | $1.8M | $462,613 |
| 2022 | 25 | 6,858 | 10,466 | $1.9M | $530,439 |
| 2021 | 27 | 6,864 | 10,717 | $1.9M | $549,476 |
| 2020 | 29 | 7,131 | 10,700 | $1.8M | $477,199 |
Total Patients
27,349
Total Services
41,643
Medicare Billing
$2.0M
Procedure Codes
115
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 771 | 1,575 | $453,600 | $141,396 | 31.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 320 | 320 | $426,880 | $112,471 | 26.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 286 | 298 | $232,424 | $45,136 | 19.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 266 | 1,058 | $111,090 | $44,661 | 40.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 323 | 328 | $127,600 | $29,462 | 23.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,993 | 3,297 | $98,910 | $21,248 | 21.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 318 | 318 | $103,032 | $15,750 | 15.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 92 | 92 | $40,572 | $11,110 | 27.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 184 | 190 | $38,000 | $10,117 | 26.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 67 | 67 | $36,113 | $9,275 | 25.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 308 | 409 | $10,225 | $3,428 | 33.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 219 | 253 | $11,385 | $3,319 | 29.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 242 | 290 | $12,760 | $3,002 | 23.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 159 | 179 | $10,203 | $2,946 | 28.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 232 | 283 | $7,358 | $2,154 | 29.3% |
| 83735 | Magnesium level | Office | 2023 | 212 | 257 | $6,425 | $1,688 | 26.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 129 | 144 | $4,608 | $1,371 | 29.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 123 | 141 | $4,371 | $1,246 | 28.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 110 | 113 | $9,153 | $1,235 | 13.5% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 46 | 47 | $2,350 | $400.68 | 17.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 31 | 32 | $928.00 | $265.28 | 28.6% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 14 | 14 | $1,106 | $264.88 | 23.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 13 | 13 | $819.00 | $234.26 | 28.6% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 16 | 16 | $736.00 | $213.76 | 29.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 15 | $810.00 | $185.45 | 22.9% |
About Amish Shah
Amish Shah is a Cardiovascular Disease healthcare provider based in Hollywood, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225057532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amish Shah has received a total of $5,242 in payments from pharmaceutical and medical device companies, with $560.11 received in 2024. These payments were reported across 279 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($5,235).
As a Medicare-enrolled provider, Shah has provided services to 27,349 Medicare beneficiaries, totaling 41,643 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Hollywood, MD
- Active Since 07/18/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1225057532
Products in Payments
- ENTRESTO (Drug) $735.02
- ELIQUIS (Drug) $593.22
- VERQUVO (Drug) $316.87
- MULTAQ (Drug) $277.50
- XARELTO (Drug) $231.35
- PRADAXA (Drug) $217.22
- JARDIANCE (Drug) $214.20
- Corlanor (Drug) $189.62
- Repatha (Biological) $180.64
- PRALUENT (Drug) $180.49
- Diamondback Peripheral (Device) $147.77
- LEQVIO (Drug) $142.50
- AVEIR (Device) $127.77
- QULIPTA (Drug) $121.43
- CoreValve Evolut (Device) $116.30
- ONYX FRONTIER (Device) $115.72
- BYSTOLIC (Drug) $97.15
- WATCHMAN (Device) $82.55
- EVIS EXERA (Device) $64.96
- VYNDAQEL (Drug) $63.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Hollywood
Yale Cohen, Md, MD
Cardiovascular Disease — Payments: $71,900
Cardiovascular Disease $71,900
John Cogan, M.d, M.D
Cardiovascular Disease — Payments: $66,965
Cardiovascular Disease $66,965
Stephen Roth, Md, MD
Cardiovascular Disease — Payments: $28,527
Cardiovascular Disease $28,527
Ariel Soffer, M.d, M.D
Cardiovascular Disease — Payments: $24,808
Cardiovascular Disease $24,808
David Steiner, M.d, M.D
Cardiovascular Disease — Payments: $12,115
Cardiovascular Disease $12,115
Maria Avila Robles, Md, MD
Cardiovascular Disease — Payments: $8,303
Cardiovascular Disease $8,303